Skip to main content
Journal of Bacteriology logoLink to Journal of Bacteriology
. 2021 Oct 12;203(21):e00399-21. doi: 10.1128/JB.00399-21

Activation of the Type VI Secretion System in the Squid Symbiont Vibrio fischeri Requires the Transcriptional Regulator TasR and the Structural Proteins TssM and TssA

Stephanie Smith a, Fernanda Salvato b, Aditi Garikipati a, Manuel Kleiner b, Alecia N Septer a,
Editor: George O'Toolec
PMCID: PMC8508121  PMID: 34370559

ABSTRACT

Bacteria have evolved diverse strategies to compete for a niche, including the type VI secretion system (T6SS), a contact-dependent killing mechanism. T6SSs are common in bacterial pathogens, commensals, and beneficial symbionts, where they affect the diversity and spatial structure of host-associated microbial communities. Although T6SS gene clusters are often located on genomic islands (GIs), which may be transferred as a unit, the regulatory strategies that promote gene expression once the T6SS genes are transferred into a new cell are not known. We used the squid symbiont Vibrio fischeri to identify essential regulatory factors that control expression of a strain-specific T6SS encoded on a GI. We found that a transcriptional reporter for this T6SS is active only in strains that contain the T6SS-encoding GI, suggesting the GI encodes at least one essential regulator. A transposon screen identified seven mutants that could not activate the reporter. These mutations mapped exclusively to three genes on the T6SS-containing GI that encode two essential structural proteins (a TssA-like protein and TssM) and a transcriptional regulator (TasR). Using T6SS reporters, reverse transcription-PCR (RT-PCR), competition assays, and differential proteomics, we found that all three genes are required for expression of many T6SS components, except for the TssA-like protein and TssM, which are constitutively expressed. Based on these findings, we propose a model whereby T6SS expression requires conserved structural proteins, in addition to the essential regulator TasR, and this ability to self-regulate may be a strategy to activate T6SS expression upon transfer of T6SS-encoding elements into a new bacterial host.

IMPORTANCE Interbacterial weapons like the T6SS are often located on mobile genetic elements, and their expression is highly regulated. We found that two conserved structural proteins are required for T6SS expression in Vibrio fischeri. These structural proteins also contain predicted GTPase and GTP binding domains, suggesting their role in promoting T6SS expression may involve sensing the energetic state of the cell. Such a mechanism would provide a direct link between T6SS activation and cellular energy levels, providing a “checkpoint” to ensure the cell has sufficient energy to build such a costly weapon. Because these regulatory factors are encoded within the T6SS gene cluster, they are predicted to move with the genetic element to activate T6SS expression in a new host cell.

KEYWORDS: type VI secretion systems, Aliivibrio fischeri, microbial interactions, genomic island, symbiosis

INTRODUCTION

Across diverse environments, bacterial populations engage in fierce competition for the limited space and resources that they require for survival and self-propagation. This competition exerts a strong selective pressure on microbes to engage in an arms race to evolve the most competitive mechanisms that incur the minimum cost. One example of a fast-evolving competitive mechanism is the type VI secretion system (T6SS). It has been predicted that T6SSs evolved from bacteriophages (1) and are often found within genomic islands (GIs) across diverse bacterial species (2). Indeed, T6SSs are encoded in the genomes of ∼25% of sequenced Gram-negative bacteria from a diversity of phyla and habitats. These bacteria are found free-living as well as associated with eukaryotic hosts, where they act as commensals (36), pathogens (720), or beneficial symbionts (2124) for insects, plants, and animals across both terrestrial and marine environments (25). This broad distribution suggests the secretion system can confer an advantage to bacteria in diverse niches on a global scale.

The T6SS killing mechanism relies on a diverse pool of polymorphic effector/immunity proteins. In Proteobacteria, 13 core proteins comprise the secretion apparatus that injects effector proteins directly into competitor cells (2632). If the competitor cell is exposed to toxic effectors for which it lacks immunity, the cell dies and lyses (33), thus allowing the space and resources that would have been consumed by its progeny to be used by the T6SS+ winner (3335). These effector/immunity genes rapidly diversify among closely related strains and species, resulting in evolved bacterial populations that are unable to occupy the same space (27, 36, 37). Thus, T6SSs are capable of shaping the diversity and even spatial distribution of microbial populations.

Bioinformatics analysis of T6SSs indicates there are distinct evolutionary lineages of T6SSs that can be acquired and lost by diverse bacterial populations (38, 39). However, in order for these horizontally acquired T6SSs to be retained in new host genomes and passed on to progeny cells, they must confer an advantage to the cell that is maintained under positive selection. This presents a dilemma—how do newly acquired T6SSs activate expression of the secretion apparatus in order to confer a beneficial function and thus ensure the genes are not lost? One possibility is that, like phages (4042), the T6SS-encoding gene clusters also encode a mechanism to self-activate. In theory, once the T6SS is expressed and confers a selective advantage to the bacterial population, its maintenance over longer time scales would allow for further integration of T6SS expression into the cellular network. Although past work has identified a large diversity of stimuli that lead to regulation of T6SSs in different bacteria for optimal use in their specific niche (19, 4345), little is known about broadly conserved regulatory factors that may allow T6SS-encoding gene clusters to activate their own expression.

Here, we use the bioluminescent squid symbiont Vibrio fischeri as a model organism to identify essential broadly conserved regulators for T6SS gene expression. V. fischeri carries two predicted T6SS gene clusters: one cluster on chromosome I (T6SS1), which is found in all sequenced V. fischeri isolates, and a second cluster on chromosome II (T6SS2) (21). Here, we focus on T6SS2, which we previously showed is located within a strain-specific genomic island and is active both in culture and in its natural host, where it is required for spatial separation of competing genotypes in different crypts within the symbiotic light organ (21). In this study, we used reporters for T6SS2 transcription and random transposon mutagenesis to identify genetic factors that are essential for T6SS2 expression in culture. In addition, we examined how in trans expression of these proteins impacts the ability of V. fischeri to modulate T6SS2 gene expression and killing ability. Finally, we used a proteomics approach to obtain a systems-level view of how these essential factors control protein expression in the cell. This study identifies broadly conserved genetic factors that are required to activate T6SS expression, which may be a strategy for self-activation to promote the dissemination of T6SSs on mobile elements.

RESULTS

T6SS2 promoter reporter activity correlates with the presence of the T6SS2 GI.

Because diverse isolates of V. fischeri display a natural genetic variation regarding the presence or absence of the T6SS2-encoding GI, this species represents a unique opportunity to examine how the prevalence of a T6SS-encoding GI impacts T6SS regulation. We hypothesized that if the GI encodes a mechanism to self-activate, then we will see a strain-specific activation of a T6SS transcriptional reporter. We used the previously described lacZ-based promoter reporter for the hcp_2 gene (44), which is the first of a putative 13-gene operon encoding several essential T6SS structural proteins (21) (Fig. 1A). The hcp gene encodes a hemolysin-coregulated protein (Hcp) that comprises the inner tube of the T6SS syringe (Fig. 1B) and is required for T6SS-mediated cytotoxicity across diverse species, including V. fischeri (11, 46, 47). We previously showed that hcp_2 promoter reporter activity and expression of core T6SS proteins are correlated and regulated by conditions in the medium: reporter activity is low in cells grown in liquid culture where no killing is apparent and is activated in cells grown on surfaces or in hydrogel, where T6SS2 proteins are more abundant and T6SS-dependent killing is observed (44). Thus, the Phcp reporter is a good indicator of T6SS2 protein expression.

FIG 1.

FIG 1

T6SS2 promoter activity is strain specific and correlates with the presence of the genomic island. (A) T6SS2 genomic island (GI) located on chromosome II of V. fischeri strain ES401 (lethal). ES401 carries an ∼50-kb gene cluster containing predicted T6SS genes on chromosome II (T6SS2) that is lacking in nonlethal strains. Regulatory genes identified in this study are indicated in black. Structural T6SS genes are indicated in gray, and hatched arrows indicate conserved genes flanking the ES401 genomic island. (B) Structural model of a T6SS inhibitor cell firing into a target cell based on V. cholerae and other systems. (C) Phcp-lacZ promoter reporter activity for 8 representative V. fischeri strains with Phcp-lacZ (pAG01 reporter), a promoterless lacZ (pAKD701 empty vector), or a vector containing a synthetic promoter to constitutively drive lacZ expression (Pcon-lacZ, pJLB207 constitutive vector). Lethality indicates ability to eliminate ES114 in a coincubation, as shown previously by Speare et al. (21). The presence of the GI was determined using PCR amplification (21). Images were taken after 24 h of incubation on LBS–X-Gal. Blue indicates increased Phcp-lacZ activity, and white indicates no Phcp-lacZ reporter activity. Experiments were performed at least four times (n = 12), and a representative experiment is shown.

To determine whether strain genotype influences Phcp reporter activity, we moved the promoterless lacZ plasmid (empty vector control) and the Phcp-lacZ reporter plasmid into eight different V. fischeri strains. We grew the control and reporter strains on agar medium supplemented with 5-bromo-4-chloro-3-indolyl-β-d-galactopyranoside (X-Gal) to observe the relative reporter activity. Promoter activity can be assessed visually using this qualitative reporter assay because the LacZ enzyme cleaves the X-Gal substrate, resulting in a blue-pigmented product. Therefore, if a promoter is highly active, colonies appear dark blue, but if the promoter is less active, colonies appear white or light blue. All strains carrying the empty vector were white on X-Gal plates, indicating little to no lacZ expression in the promoterless control (Fig. 1C). We observed strain-specific differences in color for the Phcp reporter strains: two strains lacking the GI (ES114 and PP3) were white on X-Gal plates, and all six GI-containing strains (ES213, MB13B2, H905, FQ-A001, MJ11, and ES401) were blue (Fig. 1C), including isolates whose T6SS2 is naturally nonfunctional and therefore do not kill target cells (21). To ensure that this strain-specific outcome was due to regulation of the Phcp reporter and not a result of strain-specific differences in the ability to transport and/or metabolize the X-Gal substrate, we also used a plasmid in which a constitutive promoter (Pcon) drives lacZ expression (48). All strains containing the Pcon-lacZ plasmid appeared blue on X-Gal plates (Fig. 1C). Taken together, these data indicate that the strain-specific ability to activate the Phcp-lacZ reporter correlates with the presence of the T6SS2 genomic island, suggesting one or more genes on the genomic island are required for reporter activation.

A random transposon screen reveals regulatory mutants.

To identify the essential regulators of Phcp in an unbiased way, we performed random transposon mutagenesis on the ES401 reporter strain. If the transposon disrupts a gene that is required to activate Phcp-lacZ, then the mutant reporter colony will appear white on X-Gal plates. Our initial screen of reporter activity revealed that strains containing a nonfunctional T6SS2 are still able to activate the reporter, indicating that a functional T6SS2 is not required for reporter activity (Fig. 1C). Therefore, we expected a transposon mutant screen to reveal genes specifically involved in regulation of our promoter reporter, rather than proteins required only for general T6SS function.

Strain ES401 carrying the Phcp-lacZ reporter plasmid was mutagenized using the mini-Tn5-ermR transposon delivery vector described by Lyell et al. (49) and plated onto Luria-Bertani with added salt (LBS) agar supplemented with X-Gal and the antibiotic erythromycin (Erm). Approximately 20,000 mutants were screened for colony color: seven colonies that appeared white were each given an SS strain name (e.g., SS01, SS10, etc) and selected for further characterization (Fig. 2A). To confirm that the change in phenotype was due to the transposon insertion and not a random mutation elsewhere in the genome, we used natural transformation to reconstruct each of these mutations by moving the Erm-resistant (Ermr) transposon insertion from each isolated mutant into a fresh ES401 background and repeated the Phcp-lacZ reporter assay (50). After 24 h of incubation on LBS–X-Gal plates, the ES401 wild-type strain containing Phcp-lacZ was blue; however, the remade ES401 mutant strains harboring the same reporter plasmid appeared white (see Fig. S1 in the supplemental material), indicating that Phcp was no longer activated in these strains.

FIG 2.

FIG 2

Isolated transposon mutants are unable to activate T6SS transcriptional reporters or build sheaths. (A) Qualitative reporter activity for Phcp-lacZ in wild-type ES401 and transposon mutants. “Gene” and “Base pair” indicate the location of transposon insertion for each mutant based on the ES401 reference genome (52). Daggers indicate representative mutants from tssAVF, tssM, and tasR that were selected for further characterization. Shown are fluorescence microscopy images of ES114 at 24 h following coincubation with each mutant. The scale bar is 2 mm. Images were taken after 24 h on LBS–X-Gal (reporter) or LBS (fluorescence). Assays were performed at least three times (n = 4), and a representative experiment is shown. (B) Predicted structure of TasR using Quark (80, 81). Shown are the N-terminal helix-turn-helix domain (blue), C-terminal ligand binding domain (pink), and C-terminal extension in the SS06 mutant (CLLYTSAAALGLAVVLQGP [gray]). (C) Quantitative single-cell reporter activity for Phcp-gfp in wild-type ES401, a structural tssF mutant, and representative regulatory mutants. Cells carrying plasmid pAS2028 were imaged immediately following a 5-h incubation on LBS agar, and the corrected total cell fluorescence (CTCF) was calculated for single cells. The assay was performed two times (n > 1,000 cells/treatment), and all data are shown. Circles indicate CTCF measurements from single cells. *, P < 0.0001 (one-way analysis of variance [ANOVA] followed by a Tukey’s multiple-comparison test comparing the empty vector to the Phcp-gfp reporter in each strain). (D) Representative green fluorescence images of the ES401 wild-type, a structural tssF mutant, and representative regulatory mutant cells carrying the TssB_2-GFP expression vector (pSNS119) after incubation on LBS agar for 5 h. LBS medium was supplemented with 0.5 mM IPTG (isopropyl-β-d-thiogalactopyranoside) to induce expression of TssB_2_GFP.

Because previous work by Speare et al. (21) revealed a correlation between Phcp-lacZ activity and T6SS2 function, we asked whether these mutants could no longer kill. Coincubation assays were performed as described previously by mixing a fluorescently tagged V. fischeri ES114 target strain with either wild-type or mutant ES401 strains at a 1:1 starting ratio and spotting onto LBS agar plates (21). Fluorescence microscopy was used to qualitatively observe killing by screening for the presence of fluorescently tagged ES114 after a 24-h coincubation period on agar plates. If ES114 is eliminated during the coincubation period, no fluorescence is detectable. After a 24-h coincubation, ES114 was undetectable using fluorescence microscopy when mixed with wild-type ES401, indicating that ES114 was eliminated (Fig. 2A). However, when ES114 was incubated with each of the seven ES401 mutants, fluorescent ES114 was clearly visible in the mixed colony (Fig. 2A). Taken together, these results suggest that mutants that have lost the ability to activate the hcp promoter reporter are no longer able to kill a competitor strain.

Transposon insertions map exclusively to the T6SS2 genomic island.

To identify the insertion sites, genomic DNA (gDNA) from each mutant was used in arbitrarily primed PCR (AP-PCR) or to clone out the transposon, followed by sequencing with transposon-specific primers (51). Sequences were then mapped to the ES401 genome (52). Consistent with our hypothesis that strain-specific reporter activation is due to one or more genes within the genomic island, sequencing revealed that all seven mutants contained a transposon insertion in one of three consecutive genes located on the T6SS2-encoding genomic island. Disruptions were mapped to a gene encoding an ImpA_N domain protein, tssM (icmF), and a gene encoding a predicted transcriptional regulator, which we term tasR, for type VI-associated regulator. Four of these mutants contained insertions in the gene encoding the ImpA_N domain protein (VFES401_15760), while the other transposon insertions mapped to the two genes immediately downstream: tssM (VFES401_15765) and tasR (VFES401_15770) (Fig. 1A and 2A). Moreover, the presence of multiple transposon insertions at different locations within the same genes suggests this transposon screen successfully saturated the genome.

Our transposon hits included two predicted T6SS structural proteins (ImpA_N domain protein and TssM) and a predicted transcriptional regulator (TasR). ImpA_N domain proteins, which are often referred to as TssA-like proteins, have diverse functions in T6SS assembly and function that appear to be driven by their diversified C-terminal domains (53). For example, the genome of enteroaggregative Escherichia coli (EAEC) encodes two ImpA_N domain proteins: TssAEC and TagAEC (see Fig. S2 in the supplemental material). In EAEC, TssA is essential for T6SS biogenesis, where it associates with the transmembrane structure (TssJLM) to recruit and stabilize the baseplate components (TssEFJK and VgrG) and then coordinates the assembly of the inner tube and outer sheath (Hcp and TssBC) while remaining localized to the distal end of the T6SS sheath during polymerization (54). TagAEC, which contains a transmembrane domain and VasJ domain at the C terminus, is tightly associated with the inner membrane to capture the TssA-capped distal end of the sheath, maintaining it in an extended position until fired (55). When we compared the domains and amino acid identities of our V. fischeri TssA-like protein (TssAVF) to those of other well-characterized proteins, we found that TssAVF shares less than 15% amino acid identity and it contains a distinct C-terminal domain (Fig. S2), suggesting that the role of this TssA-like protein in V. fischeri may be different from those of previously characterized proteins.

TssM is an essential structural component of the T6SS that is localized to the inner membrane and has been well characterized in other systems (2, 56). Although TssM is not predicted to have a regulatory role, previous studies have shown it has nucleoside triphosphatase (NTPase) activity in vitro (56), yet the biological relevance of this enzymatic activity is unknown. When we searched for predicted NTPase domains in TssM protein sequences from V. fischeri ES401 and other vibrios, we found Walker A and B motifs, as well as a GTP-specific binding motif in the ES401 sequence and that of closely related vibrios (see Fig. S3 in the supplemental material).

A Pfam protein sequence analysis (57) indicates TasR is a predicted Lrp/AsnC type regulator with an N-terminal helix-turn-helix domain that is predicted to bind DNA, as well as a predicted C-terminal regulatory ligand-binding domain (Fig. 2B). Lrp/AsnC-type regulators often form dimers or multimers through interactions at the ligand-binding domains, and the conformation of the multimers can change in response to binding small molecules, such as amino acids, which can alter downstream gene regulation (58). Furthermore, previous proteomics experiments indicate that the V. fischeri TasR protein is more abundant in cells grown in hydrogel, compared to low-viscosity liquid, suggesting it is regulated by environmental viscosity (44). A TasR homolog (VP1407) in Vibrio parahaemolyticus is similarly located on a predicted strain-specific genomic island (59) and was previously shown to be necessary for T6SS-dependent killing (60), indicating the importance of this regulator in other systems. Interestingly, the transposon in the tasR mutant inserted at the end of the gene, which resulted in a predicted change in the C-terminal sequence, including a 19-amino-acid extension. Given that the C terminus is a predicted ligand-binding domain, we reasoned that the disruption and additional amino acids at the C terminus may inhibit the regulatory function of TasR (Fig. 2B). Further characterizations of how disruptions in these genes impact T6SS expression and function were performed using one representative mutant for each gene: SS30 for tssAVF, SS12 for tssM, and SS06 for tasR (Fig. 2A, daggers).

Transposon mutants are unable to activate a Phcp-gfp reporter or form GFP-tagged sheaths.

Although our initial characterization of the T6SS reporter and function indicates these mutants are impaired at a population level, we set out to investigate these changes at the single-cell level by using green fluorescent protein (GFP)-based reporters of hcp_2 promoter activity and sheath assembly. We moved either a promoterless gfp plasmid (empty vector) or a Phcp-gfp reporter plasmid into wild-type ES401, a structural mutant with a disruption in the tssF_2 (vasA_2) gene (21), which encodes an essential baseplate component (61, 62), and each of our three representative transposon mutants. Following a 5-h incubation on LBS agar to allow for promoter activation, single cells from each treatment were imaged using a fluorescence microscope. Although the wild type and tssF structural mutant exhibited significantly higher fluorescence for the reporter compared to the empty vector (Fig. 2C), the tssAVF, tssM, and tasR mutants did not exhibit increased reporter activity compared to the empty vector, with reporter activity reduced by ∼94% compared to that of the wild type (Fig. 2C). Taken together, these data suggest that mutants with transposon insertions in the structural genes (tssAVF and tssM) and the regulator (tasR) are not able to activate the promoter reporter in any cells within the population.

Given that the hcp promoter is not active in these mutants, we hypothesized that these mutants are also unable to build T6SS sheaths. To directly test this hypothesis, we moved a tssB_2-gfp expression vector into each of these strains and imaged cells using fluorescence microscopy as previously described (21). The T6SS sheath is composed of TssB (VipA) and TssC (VipB) subunits, and we previously showed that T6SS2 sheaths can be observed in V. fischeri cells expressing TssB-GFP in a tssF-dependent manner (21). Although the wild-type control made visible sheaths, the tssF baseplate mutant control, as well as all three transposon mutants, was unable to build T6SS2 sheaths, and TssB_2-GFP was dispersed within cells (Fig. 2D).

Based on our initial transposon hits and mutant characterization, we considered two alternative hypotheses to explain why transposon insertions in tssAVF, tssM, and tasR prevent hcp promoter reporter activation, sheath assembly, and target killing. The first hypothesis is that these three genes are cotranscribed, and only the downstream transcriptional regulator, TasR, is required for Phcp activation. In this scenario, the transposon insertions in upstream tssAVF and tssM genes merely have a polar effect that impairs tasR expression or function. Alternatively, in addition to tasR, one or both of the structural proteins may be required for promoter activation.

Disruptions in tssAVF and tssM do not prevent tasR expression.

To begin testing our first hypothesis, we sought to determine whether the transposon insertions affected our ability to detect tasR transcripts by using a reverse transcription-PCR (RT-PCR) approach. RNA was isolated from wild-type and mutant cells, and a one-step RT-PCR was performed using multiplexed primers specific to recA and tasR sequences. We found that tasR transcripts were detectable in all three mutants (Fig. 3A), suggesting that insertions in tssAVF, tssM, and tasR (which has the transposon inserted at the end of the gene) do not prevent expression of tasR.

FIG 3.

FIG 3

Reverse transcription-PCR indicates that tssAVF, tssM, and tasR are not cotranscribed, and transposon insertions in upstream genes do not prevent tasR transcription. (A) Gel image depicting transcription of tasR and the housekeeping gene recA in wild-type ES401 and representative tssAVF, tssM, and tasR mutants based on RT-PCR results. RNA was extracted from wild-type or mutant strains following a 5-h incubation on LBS agar plates, and extractions and subsequent transcriptional analysis were performed twice. (B) Gel image depicting transcription of tssI and recA in wild-type ES401 and representative tssAVF, tssM, and tasR mutants carrying either the empty vector (vec) or a tasR expression vector. The sequences for each primer (P20/P21) can be found in Table S5. Transcriptional analysis of recA was included as a positive control. RNA was extracted following a 5-h incubation on LBS agar supplemented with 0.1 mM IPTG, and extractions and subsequent transcriptional analysis were performed twice. (C) Graphic representation of tssAVF, icmF, and tasR genes and the primers used for RT-PCR transcriptional analysis in wild-type ES401. The sequences for each primer can be found in Table S5. Dashed arrows in panel C indicate predicted promoters using the Neural Network Promoter Prediction program set to prokaryotic organisms with a minimum score of 0.9 (64). An asterisk indicates the area where nine predicted promoters were identified. Inverted white triangles indicate transposon insertion sites. Lane assignments in each set: lane 1, wild-type ES401 chromosomal DNA as the template; lane 2, wild-type ES401 cDNA as the template; lane 3, wild-type ES401 cDNA as the template, with no reverse transcriptase. RNA was extracted following a 12-h incubation on LBS agar, and extractions and subsequent transcriptional analysis were performed twice.

Overexpression of tasR is not sufficient to restore T6SS2 gene expression in structural mutants.

To further explore whether tssAVF and tssM disruptions impact T6SS regulation due to an effect on tasR expression, we asked whether overexpression of tasR in trans could restore transcription of T6SS2 genes in our mutants. Due to plasmid incompatibility issues between our reporter and expression vectors, we directly assayed the relative abundance of T6SS2 gene transcripts in strains containing the empty vector or the tasR expression vector. Because V. fischeri carries two identical copies of hcp that could not be differentiated by RT-PCR, we could not use hcp as the transcript to target. However, tssI (vgrG) is located just downstream of hcp on the T6SS2 genomic island, and the two genes have been reported to be cotranscribed in other systems (63). To test whether hcp and tssI are cotranscribed in V. fischeri, we designed primers that amplify across the hcp-tssI junction and used either wild-type ES401 genomic DNA (gDNA), RNA, or no reverse transcriptase (RT) as the template in a one-step RT-PCR. We obtained PCR products for the gDNA and RNA template but not for the no-RT control (see Fig. S4A in the supplemental material). This result indicates that hcp and tssI are cotranscribed in V. fischeri and that tssI can be used to assay Phcp transcriptional activity in our transposon mutants.

Next, we used an RT-PCR approach to assay the relative abundance of tssI transcripts in each of our mutants without and with overexpression of tasR. If overexpression of tasR in the tssAVF and tssM mutants restores tssI transcription to wild-type-like levels, this result would support our first hypothesis that disruptions in tssAVF or tssM somehow impact TasR’s ability to activate expression of hcp, tssI, and downstream structural genes for T6SS assembly and function. However, if tssI transcription in these mutants is not restored by tasR overexpression, this result would support a possible regulatory role for TssAVF and/or TssM.

Wild-type ES401 and tssAVF, tssM, or tasR mutants carrying either an IPTG (isopropyl-β-d-thiogalactopyranoside)-inducible tasR expression vector or the empty vector were incubated on LBS agar supplemented with 0.5 mM IPTG for 5 h prior to RNA isolation. Next, we used a one-step RT-PCR kit with multiplexed primers amplifying recA and tssI to assay T6SS2 transcriptional activity in our mutants without and with expression of tasR. Although we obtained PCR products for recA in all treatments, we obtained PCR products for tssI only in wild-type ES401 and the complemented tasR mutant (Fig. 3B). Taken together, these results indicate that overexpression of tasR is not sufficient to restore tssI expression in tssAVF or tssM mutants.

Reverse transcription-PCR indicates tssAVF, tssM, and tasR are not cotranscribed.

Although the above results are not consistent with possible polar effects of upstream insertions on tasR, we next wanted to directly test whether tssAVF, tssM, and tasR are possibly cotranscribed. First, we used an RT-PCR approach to experimentally determine the transcriptional units for tssAVF, tssM, and tasR. Wild-type ES401 was grown overnight on LBS agar, and total RNA was isolated and converted to cDNA using reverse transcriptase. Standard PCRs performed with primers spanning junctions between tssAVF and tssM, as well as between tssM and tasR, yielded a PCR product using both gDNA and cDNA template, initially suggesting that these genes may be cotranscribed (Fig. 3C). However, when primers were used to amplify all three genes, PCR product was only observed using gDNA template (Fig. 3C), suggesting that these three genes may not actually be cotranscribed. To resolve this apparent discrepancy, we designed a second set of primers spanning tssAVF and tssM, as well as tssM and tasR, this time with forward primers that anneal further into the upstream gene sequence (Fig. 3C). When RT-PCR was repeated with this second set of primers, we observed PCR products for only the gDNA template (Fig. 3A).

If these three genes are transcribed on independent transcripts, then we would expect to find predicted promoter sequences for tssM and tasR in their respective upstream genes. We used the Neural Network Promoter Prediction (NNPP) program (64, 65) to identify high-scoring promoter regions for each gene. Interestingly, we only found two predicted promoter sequences for tssM that were located between the two RT-PCR forward primer sites (Fig. 3C). Moreover, the NNPP results identified 10 high-scoring predicted promoters for tasR that all mapped to the sequence located between our two forward RT-PCR primer sites (Fig. 3C). Taken together, these results suggest that tssAVF, tssM, and tasR are not cotranscribed and that transposon insertions in upstream genes do not prevent tasR transcription. (Fig. 3A). Given these findings, we next chose to further explore our second hypothesis—that TasR-dependent activation of the T6SS promoter reporter may require TssAVF and/or TssM.

Coexpression of all three genes restores killing ability to transposon mutants.

If our second hypothesis is correct, and both tssAVF and tssM are required for T6SS expression, then we expect in trans complementation of the disrupted genes will restore killing function. We generated a series of IPTG-inducible expression vectors for each gene, as well as coexpression vectors of two or all three genes together. The empty vector and expression vectors were each moved into the tssAVF, tssM and tasR transposon mutants. Next, we performed coincubation assays between these ES401-derived strains and the fluorescently tagged ES114 target strain, as described above, using plates supplemented with 0.1 mM IPTG to induce gene expression. After 24 h, each coincubation spot was imaged for the presence of the tagged ES114 target. As expected, when the ES401-derived transposon mutants harbored the empty expression vector, ES114 growth was not inhibited (Fig. 4). Surprisingly, single-gene, in trans complementation only restored killing ability in the tasR mutant, suggesting that expression of the T6SS structural genes alone is not sufficient to restore killing ability for those transposon mutants (Fig. 4). We next tested the ability of our coexpression vectors to restore the ability of these mutants to kill ES114. Coexpression of tssM and tasR in trans restored killing in both tssM and tasR mutants but not the tssAVF mutant, while coexpression of all three genes in trans restored killing ability in all three transposon mutants (Fig. 4). Taken together, these results suggest that single-gene expression is not sufficient to restore killing in the tssAVF and tssM mutants, and coexpression is required.

FIG 4.

FIG 4

TssAVF, TssM, and TasR are all required to restore killing activity in mutants. (A) Fluorescence microscopy images of ES114 at 24 h following coincubation with transposon mutants carrying the empty vector or expression vectors for tssAVF, tssM, tasR, tssAVF-tssM, tssM-tasR, or tssAVF-tssM-tasR. All images were taken after a 24 h incubation on LBS agar supplemented with 0.1 mM IPTG. The scale bar is 2 mm. Assays were performed at least three times (n = 3) and a representative experiment is shown.

Overexpression of TssAVF and/or TssM prevents killing ability in the wild type.

To help interpret the coincubation assay results where expression of tssAVF and/or tssM in trans did not restore killing in the respective mutants, we examined the effect of overexpression of these genes in the wild type. We reasoned that expression of one or more of these genes could inhibit killing ability, and therefore functional complementation of killing would not be possible in these cases. We moved expression vectors for tssFG (baseplate components), tssAVF, tssM, or tasR into wild-type ES401 and repeated the coincubation assays with fluorescently tagged ES114 target on plates supplemented with different concentrations of IPTG to induce various levels of gene expression. Wild-type cells overexpressing tssFG or tasR were still able to prevent the growth of tagged ES114 at all concentrations of IPTG (Fig. 5A), indicating overexpression of these proteins does not inhibit T6SS function in the wild type. However, we observed a dose-dependent effect of tssAVF expression on the ability of the wild type to inhibit ES114 growth, with no ES114 growth inhibition at 1 mM IPTG. For wild-type cells expressing tssM, even the smallest amount of IPTG induction (0.01 mM) resulted in growth of ES114 (Fig. 5A). Taken together, these findings indicate that overexpression of some T6SS components, specifically TssAVF and TssM, prevents wild-type cells from killing ES114 target cells, providing some insight into why a single-gene expression vector may not functionally complement the tssAVF and tssM mutants.

FIG 5.

FIG 5

Overexpression of TssAVF or TssM prevents target killing. (A) Total CFU counts of the target strain (ES114) at 5 h and fluorescence microscopy images of ES114 at 24 h following coincubation with wild-type ES401 carrying expression vectors for tssFG, tssAVF, tssM, or tasR on LBS agar supplemented with either 0.01, 0.1, 0.5, or 1.0 mM IPTG as indicated. The dashed line indicates the average ES114 CFU at 0 h. (B) Percentage of wild-type ES401 CFU recovered after 5 h following an incubation on LBS agar supplemented with kanamycin and 1.0 mM IPTG to induce expression of the indicated genes. The dashed line indicates 100% recovery at 5 h, where >100% indicates net cell growth and <100% indicates net cell death. All assays were performed at least three times (n = 3), and a representative experiment is shown. All scale bars are 2 mm.

We reasoned there were several possibilities for why overexpression of certain T6SS components may prevent the wild-type cells from killing a target. First, protein overexpression could slow the growth of the wild type, making it less efficient at killing a target that can quickly outgrow it. Second, it could impact the expression of T6SS genes. Third, a stoichiometric imbalance of subunits during biogenesis of the T6SS complex could impair function, as reported previously where overexpression of the Vibrio cholerae TagA protein impaired sheath assembly and prevented T6SS-dependent killing of target cells (53). To test the first two predictions, we first quantified the change in cell abundance after 5 h by calculating the percentage of recovery for wild-type cells overexpressing different T6SS components. We found that, like many T6SS proteins, overexpression of tssAVF did not impact cell growth (Fig. 5B). However, overexpression of tssM alone, particularly the N terminus portion that encodes the predicted GTPase domains, caused the cells to die. Coexpression of tssM with tssAVF or tasR partially restored survivability, with coexpression of all three genes fully restoring survivability (Fig. 5B). These results suggest that overexpression of tssAVF does not impact cell growth, but overexpression of the N terminus of tssM is lethal to cells, except when coexpressed with tssAVF and tasR. Finally, to determine whether overexpression of tssAVF turns off T6SS gene expression, we again used our multiplexed RT-PCR assay and found that tssI was still expressed at wild-type-like levels when tssAVF was overexpressed in wild-type cells (Fig. S4B). Taken together, these data suggest that overexpression of tssAVF or tssM alone or together impairs T6SS function, unless these genes are coexpressed with tasR, thus explaining why in trans expression of tssAVF or tssM alone or together does not allow for functional complementation in the mutants (Fig. 4, orange squares). Furthermore, because the negative effects of tssAVF and/or tssM overexpression can be prevented when these proteins are coexpressed with the regulator tasR, these findings suggest that TasR-dependent activation of T6SS activity requires a functional TssAVF and TssM.

TssAVF, TssM, and TasR are all required to activate expression of T6SS structural proteins in hydrogel.

Our data indicate that TssA, TssM, and TasR are all required for activation of expression of key T6SS structural components and sheath assembly. We were therefore interested in identifying the broader regulons that these proteins control in the cellular system. To identify these regulons, we used a proteomics approach on wild-type and mutant cultures grown in liquid hydrogel. Previously, we used proteomics to show that the V. fischeri ES401 T6SS2 proteins are highly expressed and functionally active in a hydrogel medium that mimics the high-viscosity host environment (44). To determine whether our regulatory genes are also active in hydrogel, we performed coincubation assays between wild-type ES401, a tssAVF, tssM, or tasR mutant, and the ES114 target strain. Strains were coincubated in a hydrogel consisting of liquid medium supplemented with polyvinylpyrrolidone (PVP) at 5% (wt/vol) for 12 h, and ES114 CFU counts were obtained at 0 h and 12 h by spotting serial dilutions on LBS plates supplemented with antibiotics to select for ES114 target cells. As expected, when ES114 was coincubated with wild-type ES401, we observed a decrease in ES114 CFU after 12 h (see Fig. S5 in the supplemental material). However, ES114 CFU increased from 0 h to 12 h when coincubated with a tssAVF, tssM, or tasR transposon mutant, with the final ES114 CFU for mutant coincubations being significantly different from that of the coincubation with the wild type (Fig. S5). These data indicate that hydrogel is an appropriate growth condition to use to probe the regulons of TssAVF, TssM, and TasR.

We next used a proteomics approach to quantify differences in protein abundance comparing wild-type ES401 and the tssAVF, tssM, and tasR mutants. Each strain was grown in hydrogel for 24 h before cells were harvested and frozen for protein extraction, as described previously (44). We detected 1,394 proteins, or 36% of the proteins encoded in the ES401 genome (52). We then compared the proteome of each mutant to that of wild-type ES401 and constructed volcano plots of the resulting differentially abundant proteins. Proteins that were significantly more abundant in the wild-type strain compared to the mutant are shown as orange circles, and proteins that were significantly more abundant in the mutant are shown as blue circles (Fig. 6A). All other proteins that did not pass our threshold values for being significantly differentially abundant are shown as gray squares. Only 11 to 14 proteins were differentially abundant comparing wild-type and mutant treatments, with the majority of these proteins being T6SS components (Fig. 6B and C; see Tables S1 to S4 in the supplemental material). Together, these data suggest that in addition to their structural roles in T6SS function, TssAVF and TssM, along with the regulator TasR, are required for expression of a relatively small regulon composed primarily of the T6SS components necessary for killing competitor strains.

FIG 6.

FIG 6

TssAVF, TssM, and TasR are required to activate expression of T6SS structural proteins in hydrogel. (A) Volcano plots showing the log2 fold difference in protein abundance between the T6SS2 mutant and wild-type ES401. Proteins with a negative log2 fold change are more abundant in wild-type ES401 (left; orange), and proteins with a positive log2 fold change are more abundant in the mutant (right [blue]). Data points above the dashed line had significant P values between treatments (Student's t test with the Bonferroni correction, P < 0.017), and those outside the vertical dashed lines had a magnitude fold change of >1 log2 between treatments. (B) Table describing the log2 fold change (mutant versus WT) of all proteins that were significantly differentially expressed between the mutant and wild type in at least one treatment. Underlined log2 fold change indicates significantly differently expressed compared to the wild type (Bonferroni corrected α = 0.017). NSAF values of zero were replaced with the limit of detection (0.000762) for calculation of log2 fold change values. Heat map colors were assigned expression levels of high (orange) to low (blue) based on log2 fold change values. (C) Structural T6SS2 proteins. Orange indicates that the protein was differentially expressed between wild-type ES401 and at least one of the regulatory mutants (Student's t test with the Bonferroni correction, P < 0.017).

DISCUSSION

This study aimed to identify essential regulators of the promoter that activates expression of T6SS2 structural proteins. Our global search for regulators yielded a surprising result: two broadly conserved structural proteins are required for T6SS protein expression. Interestingly, our previous work showed that although the majority of T6SS-associated proteins were significantly more abundant in hydrogel compared to liquid, including the essential regulator TasR, peptides specific to TssAVF and TssM were not differentially abundant under either condition (44), suggesting these proteins are constitutively expressed. Moreover, the V. fischeri TssM protein contains predicted GTPase-related domains that are conserved in other TssM homologs (see Fig. S3 in the supplemental material), and work with Agrobacterium tumefaciens showed TssM has ATPase activity in vitro (56), providing further support that these domains have an unknown biological function. Finally, TssAVF contains a predicted GTP binding domain and a unique C-terminal region that is not found in other well-characterized TssA-like proteins (Fig. S2).

The presence of GTP-related domains in proteins that are required for expression of other T6SS structural proteins provides a connection, albeit a speculative one, between sensing of cellular energy levels and expression of this costly competitive mechanism. Although future work will be required to understand how cells may ensure the T6SS is expressed only when cellular energy stores are sufficient to support its assembly and deployment, TssAVF and TssM would appear to be logical targets of future exploration. Indeed, prokaryotic GTPases are known to play roles in diverse cellular processes, including the stringent response (66). When nutrients are low, cells produce the signaling molecule (p)ppGpp, which is derived from GDP and GTP. In E. coli, (p)ppGpp inhibits the GTPase activity of Der, possibly by binding to the GTP binding site, which regulates its activity under stress conditions (67). If the TssM GTPase motifs are functional in the cell, it seems reasonable to hypothesize a similar mechanism for T6SS regulation, where the cell uses a constitutively expressed essential structural protein to sense the intracellular energy levels to prevent expression of the T6SS when nutrients are limiting. Future work that focuses on determining the activity of these predicted GTPase-related domains, as well as the subcellular locations and possible physical interactions among these proteins, will be essential to fully understand the roles of these proteins in T6SS regulation and function.

Our proposed model, which posits that the constitutively expressed TssAVF and TssM proteins play a key role in activating T6SS expression, would be particularly important for activating T6SS expression if the GI is transferred into a new bacterial host. Indeed, the ability of genes on mobile elements to self-regulate is not without precedent. For example, the predicted ancestors of T6SSs, phages, are known to self-activate gene expression as lytic viruses and as prophages that self-activate in response to stimuli such as DNA damage (40). Moreover, recent work in Burkholderia thailandensis demonstrated that another contact-dependent inhibitory system, known as CDI, which is encoded in the bcp genes, is located on a new class of transposable elements (68). When the mobile element transfers into a new bacterial host, it brings with it the genes necessary for activation of the CDI system. Here, we present preliminary data that are consistent with a similar mechanism of self-activation for T6SSs encoded on a genomic island. However, future work is needed to understand the molecular mechanism by which TssAVF and TssM promote T6SS expression and to determine how this possible self-activation mechanism is integrated into other species-specific regulatory networks to optimize T6SS expression and enhance competition for a specific niche.

MATERIALS AND METHODS

Media and growth conditions.

V. fischeri strains were grown in LBS medium at 24°C, and E. coli strains were grown in either LB medium or brain heart infusion (BHI) (Difco) at 37°C. Antibiotic selection for V. fischeri and E. coli strains was described previously (69). Briefly, for selection in E. coli cultures, chloramphenicol (Cm) and kanamycin were added to LB medium at final concentrations of 20 and 40 μg ml−1, respectively, and erythromycin (Erm) was added to BHI medium at a final concentration of 150 μg ml−1. For selection in V. fischeri cultures, chloramphenicol, kanamycin, and erythromycin were added to LBS medium at final concentrations of 2, 100, and 5 μg ml−1, respectively. Plasmids with the R6Kγ origin of replication were maintained in E. coli strain DH5α λpir (69), and plasmid pEVS104 (70) was maintained in strain CC118 λpir (71). All other plasmids were maintained in E. coli strain DH5α (72).

Molecular techniques.

PCR was performed on a Mastercycler Pro (Eppendorf) using Phusion high-fidelity DNA polymerase (New England Biolabs), except where noted. PCR products were purified using the DNA Clean and Concentrater-5 kit (Zymo Research, Orange, CA). Plasmids were isolated using the ZR Plasmid Miniprep Classic kit (Zymo Research, Orange, CA). The DNA concentration was measured with a BioSpectrometer Basic (Eppendorf). Sequencing was performed through Eton Biosciences or GENEWIZ and analyzed using A plasmid Editor (ApE).

Transposon mutagenesis.

Triparental matings were set up between V. fischeri strain ES401 carrying Phcp-lacZ-reporter pAG01, the mini-Tn5-ermR transposon vector pEVS170, and conjugative helper pEVS104 as previously described (49, 70). After a 24-h incubation period on LBS agar at 24°C, mating spots were resuspended in 1 ml LBS medium and spread plated onto LBS agar medium containing Erm and 50 μg ml−1 5-bromo-4-chloro-3-indolyl-β-d-galactoside (X-Gal). A total of ∼20,000 mutant colonies were screened for blue or white coloration.

(i) Arbitrarily primed PCR. For the first round of arbitrarily primed PCR (AP-PCR), the transposon-specific primer 170Int2 and a random oligonucleotide, ARB1, were used to amplify DNA extracted from ES401 transposon mutants. Because of the low stringency that results from using random oligonucleotides, a second round of PCR was performed. This reaction used a second transposon-specific primer and random oligonucleotide (170Ext3/ARB2), which further enriched the amplification of the transposon insertion junction (73). To identify the site of transposon integration, the AP-PCR product for ES401 mutants SS01 and SS32 was sequenced using primer 170EXT and mapped using V. fischeri ES401 as a reference genome.

(ii) Cloning into DH5α λpir. Transposon insertion sites for ES401 mutants SS06, SS10, SS12, SS14, and SS30 were determined by cloning out the transposon and flanking DNA and then sequencing across the transposon-chromosome junction using primer M13F. Briefly, chromosomal DNA was digested with HhaI restriction enzyme, and fragments were self-ligated with T4 DNA ligase. The resulting circularized transposon and flanking DNA was transformed into E. coli strain DH5α λpir and selected for using the Erm resistance gene contained within the transposon (74).

Strain and plasmid construction.

The bacterial strains, plasmids, and oligonucleotides used in this study are presented in Table S5 in the supplemental material. The resulting plasmids were mobilized into recipients by triparental mating using CC118 λpir/pEVS104 as a conjugative helper. All primer design was based on the MJ11 genome sequence, unless otherwise noted, and primers were synthesized by Eton Biosciences or Integrated DNA Technologies (IDT).

To reconstruct ES401 transposon mutants in a fresh wild-type background, genomic DNA was isolated from overnight cultures of mutant strains grown in LBS at 24°C. Overnight cultures of wild-type ES401 carrying the pLosTfoX plasmid were grown in Fischeri minimal medium (FMM) supplemented with Cm and N-acetylglucosamine (GlcNAc; 10 μM). Natural transformation was performed according to Pollack-Berti et al. (50). Ermr colonies were considered transformants and were referred to as “reconstructed mutants” in subsequent experiments.

To construct an expression vector for the tasR mutation, tasR was PCR amplified from strain ES401 gDNA using primers ANS1167 and P27. The forward primer includes 21 bp upstream of the start codon to include the native ribosome binding site (RBS). The reverse primer included the native stop codon to prevent a translational fusion to, or expression of, the downstream gfp gene on pAKD601. The resulting tasR PCR product was cloned into the KpnI- and XbaI-cut sites of plasmid pAKD601, located downstream of an IPTG-inducible promoter, resulting in plasmid pSNS111.

To construct an expression vector for the tssAVF mutation, tssA_2 was PCR amplified from strain ES401 gDNA using primers P103 and P104. The forward primer included a 15-bp region encoding an RBS, and the reverse primer included the native stop codon to prevent a translational fusion to, or expression of, the downstream gfp gene on pAKD601. The resulting tssA_2 PCR product was cloned into the KpnI- and XbaI-cut sites of plasmid pAKD601, located downstream of an IPTG-inducible promoter in plasmid, resulting in plasmid pSNS114.

To construct an expression vector for both the tssM and tasR genes, tssM_2 and tasR were PCR amplified together from strain ES401 gDNA using primers P78 and P71. The forward primer includes 8 bp upstream of the start codon to include the native RBS. The reverse primer includes the native stop codon to prevent a translational fusion to, or expression of, the downstream gfp gene on pAKD601. The resulting tssM_2-tasR PCR product was cloned downstream of an IPTG-inducible promoter in plasmid pAKD601 (cut with KpnI and NheI) using the standard SLIC cloning technique (75), resulting in plasmid pSNS126.

To construct an expression vector for the tssM mutation, the plasmid pSNS126 was PCR amplified using primers SNS95 and SNS96, which were designed to amplify around the plasmid and exclude the tasR gene. The resulting pSNS126 PCR product was phosphorylated using T4 polynucleotide kinase (PNK), and a DpnI digest was performed to eliminate any remaining methylated template vector. This product was ligated and transformed into DH5α λpir, resulting in vector pSNS131.

To construct an expression vector for both the tssAVF and tssM mutations, tssA_2 and tssM_2 were PCR amplified together from strain ES401 gDNA using primers P117 and P119. The forward primer included a 15-bp region encoding the RBS sequence (AGGAGGAAATTAAGC). The reverse primer included the native stop codon to prevent a translational fusion to, or expression of, the downstream gfp gene on pAKD601. The resulting tssA_2-tssM_2 PCR product was cloned downstream of an IPTG-inducible promoter in plasmid pAKD601 (cut with KpnI and NheI) using the standard SLIC cloning technique (75), resulting in plasmid pSNS142.

To construct an expression vector for the tssAVF, tssM, and tasR mutations, tssA_2, tssM_2, and tasR were PCR amplified together from strain ES401 gDNA using primers P103 and P27. The forward primer included a 15-bp region encoding the RBS from plasmid pTM214. The reverse primer included the native stop codon to prevent a translational fusion to, or expression of, the downstream gfp gene on pAKD601. The resulting tssA_2-tssM_2-tasR PCR product was cloned downstream of an IPTG-inducible promoter in plasmid pAKD601 (cut with KpnI and NheI) using the standard SLIC cloning technique (75), resulting in plasmid pSNS143.

To construct the gfp-based hcp_2 promoter reporter, the hcp_2 promoter sequence was PCR amplified from plasmid pAG01 using primers AS1094 and AS1095. Plasmid pJLS71 (ref PMID 29752265) was PCR amplified using primers AS1092 and AS1093. PCR products were digested with DpnI to remove methylated template, and resulting PCR products were combined with SLIC, as described above, resulting in plasmid pAS2028.

lacZ-based reporter assays.

V. fischeri strains carrying the Phcp-lacZ reporter were grown overnight on LBS agar plates supplemented with the appropriate antibiotic at 24°C. Cells were scraped from agar surfaces, resuspended in LBS medium, and diluted to an optical density at 600 nm (OD600) of 1.0. For each strain, 5 μl of culture was spotted on LBS agar plates containing 1.0 mM X-Gal and incubated at 24°C. After 24 h, representative spots from each strain were imaged using a Pluggable USB2-MICRO-250× digital microscope. Each experiment was repeated three times with four independent cultures of each strain.

Coincubation assays.

V. fischeri strains containing either pVSV102 (GFP) or pVSV208 (dsRed) were grown overnight on LBS agar plates supplemented with the appropriate antibiotic at 24°C. Cells were scraped from agar surfaces, resuspended in LBS medium, and diluted to an OD600 of 1.0. For each coincubation, strains were mixed in a 1:1 ratio, and either 5 μl of the mixture was applied as spots onto either LBS agar plates supplemented with IPTG when needed, or cells were mixed in 5% PVP hydrogel medium as described by Speare et al. (44) and incubated at 24°C. After 5 h, coincubations from LBS agar were resuspended in 1 ml LBS medium. Strains were quantified by plating serial dilutions for T0 (initial) and T-Final (resuspended after coincubation period) onto LBS plates supplemented with antibiotics selective for each strain. Each experiment was repeated four times with three independent cultures of each strain.

Fluorescence microscopy.

For each coincubation assay, fluorescence microscopy images were taken with a trinocular zoom stereo microscope equipped with a Nightsea fluorescence adapter kit for green and red fluorescence detection. Images were taken using an OMAX 14MP camera with OMAX ToupView camera control software. Color changes were made by adjusting the lookup value to “Green” in FIJI. No brightness or contrast adjustments were made. For single-cell imaging of T6SS transcriptional reporter and TssB_2-GFP sheaths, images were taken with an Olympus BX51 microscope outfitted with a Hamamatsu C8484-03G01 camera and a 100×/1.30 Oil Ph3 lens objective as described previously (21).

Reverse transcription-PCR.

RNA was extracted from wild-type or mutant V. fischeri strains following incubation for 5 or 12 h at 24°C on LBS agar plates supplemented with the appropriate antibiotic and IPTG when indicated. RNA extractions were performed according to the ZR Fungal/Bacterial RNA Miniprep kit (Zymo Research, Orange, CA). Transcriptional analysis was performed according to the ONETAQ One-Step RT-PCR kit (NEB, Ipswich, MA), and similar concentrations of DNA, RNA, or cDNA were added to PCR mixtures within experiments. All RT-PCR experiments were performed on two separate occasions with RNA derived from separate extractions, each with similar results.

Sample preparations for proteomics.

We performed sample preparation as described by Speare et al. (44). Briefly, we added 60 μl of SDT lysis buffer (4% [wt/vol] SDS, 100 mM Tris-HCl, 0.1 M dithiothreitol [DTT]) to each cell pellet and then incubated the samples at 95°C for 10 min for cell lysis. Tryptic digests of protein extracts were prepared following the filter-aided sample preparation (FASP) protocol described by Wisniewski et al. (76). In addition to minor modifications as described in Kleiner et al. (77), we loaded the whole lysate on to the filter units used for the FASP procedure. Peptide concentrations were determined with the Pierce Micro BCA (bicinchoninic acid) assay (Thermo Scientific) using an Epoch2 microplate reader (Biotek) following the manufacturer’s instructions.

LC-MS/MS.

Four hundred nanograms of peptides for each sample was analyzed by one-dimensional liquid chromatography-tandem mass spectrometry (1D LC-MS/MS) as described by Speare et al. (44). Briefly, peptides were loaded with an UltiMate 3000 RSLCnano liquid chromatograph (Thermo Fisher Scientific) in loading solvent A (2% acetonitrile, 0.05% trifluoroacetic acid) onto a 5-mm, 300-μm ID C18 Acclaim PepMap100 precolumn (Thermo Fisher Scientific). Peptides were separated on the analytical column (75-cm by 75-μm analytical EASY-Spray column packed with PepMap RSLC C18, 2-μm material; Thermo Fisher Scientific) by using a 140-min gradient, and mass spectrometry analyses was performed on a Q Exactive HF hybrid quadrupole Orbitrap (Thermo Fisher Scientific) are described by Speare et al. (44).

Protein identification and statistical analysis.

A database containing protein sequences from V. fischeri ES401 (SRJG00000000.1) downloaded from NCBI (https://www.ncbi.nlm.nih.gov/Traces/wgs/SRJG01) was used. Sequences of common laboratory contaminants were included by appending the cRAP protein sequence database (http://www.thegpm.org/crap/). The final database contained 3,925 protein sequences. Searches of the MS/MS spectra against this database were performed with the Sequest HT node in Proteome Discoverer version 2.2.0.388 (Thermo Fisher Scientific) as described by Speare et al. (44). Only proteins identified with medium or high confidence were retained, resulting in an overall false-discovery rate of <5%. For protein quantification, normalized spectral abundance factors (NSAFs) (78) were calculated and multiplied by 100 to obtain the relative percentage of protein abundance.

Contingency tables were generated by comparing average protein abundance for the wild type compared to each mutant strain using Student’s t test, corrected for multiple comparisons using a Bonferroni correction. Volcano plots were generated for each mutant strain by graphing the negative log10 P value and log2 fold change. NSAF values of 0 were replaced by the limit of detection value of 0.000762 to allow for comparisons of the log2 fold change between treatments.

Data availability.

The mass spectrometry proteomics data and protein sequence database have been deposited in the ProteomeXchange Consortium via the PRIDE (79) partner repository under the data set identifier PXD017722.

ACKNOWLEDGMENTS

We thank Peggy Cotter, Barbara MacGregor, and Scott Gifford for helpful discussions, as well Ned Ruby and Eric Stabb for supplying previously isolated V. fischeri strains and plasmids. We also thank Andreas Teske for providing the use of his epifluorescence microscope.

S.S. and A.N.S. were supported by NIGMS grant R35 GM137886, and S.S. was supported by a Department of Defense-funded National Defense Science and Engineering Graduate Fellowship. The proteomics work was supported by the NC State Chancellor’s Faculty Excellence Program Cluster on Microbiomes and Complex Microbial Communities (M.K.) and by the USDA National Institute of Food and Agriculture, Hatch project 1014212 (M.K.). We made all LC-MS/MS measurements in the Molecular Education, Technology, and Research Innovation Center (METRIC) at NC State University.

S.S. and A.N.S. designed the study. S.S., A.G., and A.N.S. acquired, analyzed, or interpreted data. S.S. and A.N.S. wrote the manuscript. F.S. contributed sample preparation, LC-MS/MS analyses, and data processing and analysis, and M.K. contributed experimental design and supervision of proteomics experiments.

Footnotes

Supplemental material is available online only.

Supplemental file 1
Table S1. Download JB.00399-21-s0001.xlsx, XLSX file, 0.3 MB (299KB, xlsx)
Supplemental file 2
Table S2. Download JB.00399-21-s0002.xlsx, XLSX file, 0.09 MB (95.5KB, xlsx)
Supplemental file 3
Table S3. Download JB.00399-21-s0003.xlsx, XLSX file, 0.09 MB (96.6KB, xlsx)
Supplemental file 4
Table S4. Download JB.00399-21-s0004.xlsx, XLSX file, 0.09 MB (95.5KB, xlsx)
Supplemental file 5
Fig. S1 to S5 and Table S5. Download JB.00399-21-s0005.pdf, PDF file, 0.3 MB (434.4KB, pdf)

Contributor Information

Alecia N. Septer, Email: asepter@email.unc.edu.

George O'Toole, Geisel School of Medicine at Dartmouth.

REFERENCES

  • 1.Leiman PG, Basler M, Ramagopal UA, Bonanno JB, Sauder JM, Pukatzki S, Burley SK, Almo SC, Mekalanos JJ. 2009. Type VI secretion apparatus and phage tail-associated protein complexes share a common evolutionary origin. Proc Natl Acad Sci USA 106:4154–4159. 10.1073/pnas.0813360106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Ho BT, Dong TG, Mekalanos JJ. 2014. A view to a kill: the bacterial type VI secretion system. Cell Host Microbe 15:9–21. 10.1016/j.chom.2013.11.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Steele MI, Kwong WK, Whiteley M, Moran NA. 2017. Diversification of type VI secretion system toxins reveals ancient antagonism among bee gut microbes. mBio 8:e01630-17. 10.1128/mBio.01630-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Chatzidaki-Livanis M, Geva-Zatorsky N, Comstock LE. 2016. Bacteroides fragilis type VI secretion systems use novel effector and immunity proteins to antagonize human gut Bacteroidales species. Proc Natl Acad Sci USA 113:3627–3632. 10.1073/pnas.1522510113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Marden JN, McClure EA, Beka L, Graf J. 2016. Host matters: medicinal leech digestive-tract symbionts and their pathogenic potential. Front Microbiol 7:1569. 10.3389/fmicb.2016.01569. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Alex A, Antunes A. 2019. Comparative genomics reveals metabolic specificity of Endozoicomonas isolated from a marine sponge and the genomic repertoire for host-bacteria symbioses. Microorganisms 7:635. 10.3390/microorganisms7120635. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Li L, Meng H, Gu D, Li Y, Jia M. 2019. Molecular mechanisms of Vibrio parahaemolyticus pathogenesis. Microbiol Res 222:43–51. 10.1016/j.micres.2019.03.003. [DOI] [PubMed] [Google Scholar]
  • 8.Dubert J, Barja JL, Romalde JL. 2017. New insights into pathogenic Vibrios affecting bivalves in hatcheries: present and future prospects. Front Microbiol 8:762. 10.3389/fmicb.2017.00762. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Church SR, Lux T, Baker-Austin C, Buddington SP, Michell SL. 2016. Vibrio vulnificus type 6 secretion system 1 contains anti-bacterial properties. PLoS One 11:e0165500. 10.1371/journal.pone.0165500. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Wu H-Y, Chung P-C, Shih H-W, Wen S-R, Lai E-M. 2008. Secretome analysis uncovers an Hcp-family protein secreted via a type VI secretion system in Agrobacterium tumefaciens. J Bacteriol 190:2841–2850. 10.1128/JB.01775-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Bernal P, Allsopp LP, Filloux A, Llamas MA. 2017. The Pseudomonas putida T6SS is a plant warden against phytopathogens. ISME J 11:972–987. 10.1038/ismej.2016.169. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Sana TG, Flaugnatti N, Lugo KA, Lam LH, Jacobson A, Baylot V, Durand E, Journet L, Cascales E, Monack DM. 2016. Salmonella typhimurium utilizes a T6SS-mediated antibacterial weapon to establish in the host gut. Proc Natl Acad Sci USA 113:E5044–E5051. 10.1073/pnas.1608858113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Fu Y, Waldor MK, Mekalanos JJ. 2013. Tn-Seq analysis of Vibrio cholerae intestinal colonization reveals a role for T6SS-mediated antibacterial activity in the host. Cell Host Microbe 14:652–663. 10.1016/j.chom.2013.11.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Chen H, Yang D, Han F, Tan J, Zhang L, Xiao J, Zhang Y, Liu Q. 2017. The bacterial T6SS effector EvpP prevents NLRP3 inflammasome activation by inhibiting the Ca2+-dependent MAPK-Jnk pathway. Cell Host Microbe 21:47–58. 10.1016/j.chom.2016.12.004. [DOI] [PubMed] [Google Scholar]
  • 15.Guillemette R, Ushijima B, Jalan M, Häse CC, Azam F. 2020. Insight into the resilience and susceptibility of marine bacteria to T6SS attack by Vibrio cholerae and Vibrio coralliilyticus. PLoS One 15:e0227864. 10.1371/journal.pone.0227864. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Murdoch SL, Trunk K, English G, Fritsch MJ, Pourkarimi E, Coulthurst SJ. 2011. The opportunistic pathogen Serratia marcescens utilizes type VI secretion to target bacterial competitors. J Bacteriol 193:6057–6069. 10.1128/JB.05671-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Journet L, Cascales E. 31 January 2021, posting date. The type VI secretion system in Escherichia coli and related species. EcoSal Plus 2015 10.1128/ecosalplus.ESP-0009-2015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Perault AI, Chandler CE, Rasko DA, Ernst RK, Wolfgang MC, Cotter PA. 2020. Host adaptation predisposes Pseudomonas aeruginosa to type VI secretion system-mediated predation by the Burkholderia cepacia complex. Cell Host Microbe 28:534–547.e3. 10.1016/j.chom.2020.06.019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Chen L, Zou Y, She P, Wu Y. 2015. Composition, function, and regulation of T6SS in Pseudomonas aeruginosa. Microbiol Res 172:19–25. 10.1016/j.micres.2015.01.004. [DOI] [PubMed] [Google Scholar]
  • 20.Calder A, Snyder L. 2020. The type VI secretion system in commensal Neisseria spp. Access Microbiol 2:116. 10.1099/acmi.ac2020.po0060. [DOI] [Google Scholar]
  • 21.Speare L, Cecere AG, Guckes KR, Smith S, Wollenberg MS, Mandel MJ, Miyashiro T, Septer AN. 2018. Bacterial symbionts use a type VI secretion system to eliminate competitors in their natural host. Proc Natl Acad Sci USA 115:E8528–E8537. 10.1073/pnas.1808302115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Wexler AG, Bao Y, Whitney JC, Bobay L-M, Xavier JB, Schofield WB, Barry NA, Russell AB, Tran BQ, Goo YA, Goodlett DR, Ochman H, Mougous JD, Goodman AL. 2016. Human symbionts inject and neutralize antibacterial toxins to persist in the gut. Proc Natl Acad Sci USA 113:3639–3644. 10.1073/pnas.1525637113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Bernal P, Llamas MA, Filloux A. 2018. Type VI secretion systems in plant‐associated bacteria. Environ Microbiol 20:1–15. 10.1111/1462-2920.13956. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Yang Y, Sun J, Sun Y, Kwan YH, Wong WC, Zhang Y, Xu T, Feng D, Zhang Y, Qiu J-W, Qian P-Y. 2020. Genomic, transcriptomic, and proteomic insights into the symbiosis of deep-sea tubeworm holobionts. ISME J 14:135–150. 10.1038/s41396-019-0520-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Kempnich MW, Sison-Mangus MP. 2020. Presence and abundance of bacteria with the type VI secretion system in a coastal environment and in the global oceans. PLoS One 15:e0244217. 10.1371/journal.pone.0244217. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Zheng J, Leung KY. 2007. Dissection of a type VI secretion system in Edwardsiella tarda. Mol Microbiol 66:1192–1206. 10.1111/j.1365-2958.2007.05993.x. [DOI] [PubMed] [Google Scholar]
  • 27.Alcoforado Diniz J, Liu YC, Coulthurst SJ. 2015. Molecular weaponry: diverse effectors delivered by the type VI secretion system. Cell Microbiol 17:1742–1751. 10.1111/cmi.12532. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Boyer F, Fichant G, Berthod J, Vandenbrouck Y, Attree I. 2009. Dissecting the bacterial type VI secretion system by a genome wide in silico analysis: what can be learned from available microbial genomic resources? BMC Genomics 10:104. 10.1186/1471-2164-10-104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Russell AB, Wexler AG, Harding BN, Whitney JC, Bohn AJ, Goo YA, Tran BQ, Barry NA, Zheng H, Peterson SB, Chou S, Gonen T, Goodlett DR, Goodman AL, Mougous JD. 2014. A type VI secretion-related pathway in Bacteroidetes mediates interbacterial antagonism. Cell Host Microbe 16:227–236. 10.1016/j.chom.2014.07.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Klein TA, Ahmad S, Whitney JC. 2020. Contact-dependent interbacterial antagonism mediated by protein secretion machines. Trends Microbiol 28:387–400. 10.1016/j.tim.2020.01.003. [DOI] [PubMed] [Google Scholar]
  • 31.Coulthurst S. 2019. The type VI secretion system: a versatile bacterial weapon. Microbiology (Reading) 165:503–515. 10.1099/mic.0.000789. [DOI] [PubMed] [Google Scholar]
  • 32.Hernandez RE, Gallegos-Monterrosa R, Coulthurst SJ. 2020. Type VI secretion system effector proteins: effective weapons for bacterial competitiveness. Cell Microbiol 22:e13241. 10.1111/cmi.13241. [DOI] [PubMed] [Google Scholar]
  • 33.Smith WP, Vettiger A, Winter J, Ryser T, Comstock LE, Basler M, Foster KR. 2020. The evolution of the type VI secretion system as a disintegration weapon. PLoS Biol 18:e3000720. 10.1371/journal.pbio.3000720. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Matthey N, Stutzmann S, Stoudmann C, Guex N, Iseli C, Blokesch M. 2019. Neighbor predation linked to natural competence fosters the transfer of large genomic regions in Vibrio cholerae. eLife 8:e48212. 10.7554/eLife.48212. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Borgeaud S, Metzger LC, Scrignari T, Blokesch M. 2015. The type VI secretion system of Vibrio cholerae fosters horizontal gene transfer. Science 347:63–67. 10.1126/science.1260064. [DOI] [PubMed] [Google Scholar]
  • 36.Kostiuk B, Unterweger D, Provenzano D, Pukatzki S. 2017. T6SS intraspecific competition orchestrates Vibrio cholerae genotypic diversity. Int Microbiol 20:130–137. 10.2436/20.1501.01.294. [DOI] [PubMed] [Google Scholar]
  • 37.Fridman CM, Keppel K, Gerlic M, Bosis E, Salomon D. 2020. A comparative genomics methodology reveals a widespread family of membrane-disrupting T6SS effectors. Nat Commun 11:1085. 10.1038/s41467-020-14951-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Bingle LE, Bailey CM, Pallen MJ. 2008. Type VI secretion: a beginner's guide. Curr Opin Microbiol 11:3–8. 10.1016/j.mib.2008.01.006. [DOI] [PubMed] [Google Scholar]
  • 39.Böck D, Medeiros JM, Tsao H-F, Penz T, Weiss GL, Aistleitner K, Horn M, Pilhofer M. 2017. In situ architecture, function, and evolution of a contractile injection system. Science 357:713–717. 10.1126/science.aan7904. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Waldor MK, Friedman DI. 2005. Phage regulatory circuits and virulence gene expression. Curr Opin Microbiol 8:459–465. 10.1016/j.mib.2005.06.001. [DOI] [PubMed] [Google Scholar]
  • 41.Wagner PL, Livny J, Neely MN, Acheson DW, Friedman DI, Waldor MK. 2002. Bacteriophage control of Shiga toxin 1 production and release by Escherichia coli. Mol Microbiol 44:957–970. 10.1046/j.1365-2958.2002.02950.x. [DOI] [PubMed] [Google Scholar]
  • 42.Wagner PL, Neely MN, Zhang X, Acheson DW, Waldor MK, Friedman DI. 2001. Role for a phage promoter in Shiga toxin 2 expression from a pathogenic Escherichia coli strain. J Bacteriol 183:2081–2085. 10.1128/JB.183.6.2081-2085.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Bernard CS, Brunet YR, Gueguen E, Cascales E. 2010. Nooks and crannies in type VI secretion regulation. J Bacteriol 192:3850–3860. 10.1128/JB.00370-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Speare L, Smith S, Salvato F, Kleiner M, Septer AN. 2020. Environmental viscosity modulates interbacterial killing during habitat transition. mBio 11:e03060-19. 10.1128/mBio.03060-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Miyata ST, Bachmann V, Pukatzki S. 2013. Type VI secretion system regulation as a consequence of evolutionary pressure. J Med Microbiol 62:663–676. 10.1099/jmm.0.053983-0. [DOI] [PubMed] [Google Scholar]
  • 46.Pukatzki S, Ma AT, Sturtevant D, Krastins B, Sarracino D, Nelson WC, Heidelberg JF, Mekalanos JJ. 2006. Identification of a conserved bacterial protein secretion system in Vibrio cholerae using the Dictyostelium host model system. Proc Natl Acad Sci USA 103:1528–1533. 10.1073/pnas.0510322103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Hood RD, Singh P, Hsu F, Güvener T, Carl MA, Trinidad RRS, Silverman JM, Ohlson BB, Hicks KG, Plemel RL, Li M, Schwarz S, Wang WY, Merz AJ, Goodlett DR, Mougous JD. 2010. A type VI secretion system of Pseudomonas aeruginosa targets a toxin to bacteria. Cell Host Microbe 7:25–37. 10.1016/j.chom.2009.12.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Bose JL, Wollenberg MS, Colton DM, Mandel MJ, Septer AN, Dunn AK, Stabb EV. 2011. Rapid evolution of the luxR-luxI intergenic region has contributed to the diverse bioluminescence output of Vibrio fischeri strains isolated from different environments. Appl Environ Microbiol 77:2445–2457. 10.1128/AEM.02643-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Lyell NL, Dunn AK, Bose JL, Vescovi SL, Stabb EV. 2008. Effective mutagenesis of Vibrio fischeri by using hyperactive mini-Tn5 derivatives. Appl Environ Microbiol 74:7059–7063. 10.1128/AEM.01330-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Pollack‐Berti A, Wollenberg MS, Ruby EG. 2010. Natural transformation of Vibrio fischeri requires tfoX and tfoY. Environ Microbiol 12:2302–2311. 10.1111/j.1462-2920.2010.02250.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Brennan CA, Mandel MJ, Gyllborg MC, Thomasgard KA, Ruby EG. 2013. Genetic determinants of swimming motility in the squid light‐organ symbiont Vibrio fischeri. Microbiologyopen 2:576–594. 10.1002/mbo3.96. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Bultman KM, Cecere AG, Miyashiro T, Septer AN, Mandel MJ. 2019. Draft genome sequences of type VI secretion system-encoding Vibrio fischeri strains FQ-A001 and ES401. Microbiol Resour Announc 8:e00385-19. 10.1128/MRA.00385-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Schneider JP, Nazarov S, Adaixo R, Liuzzo M, Ringel PD, Stahlberg H, Basler M. 2019. Diverse roles of TssA‐like proteins in the assembly of bacterial type VI secretion systems. EMBO J 38:e100825. 10.15252/embj.2018100825. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Zoued A, Durand E, Brunet YR, Spinelli S, Douzi B, Guzzo M, Flaugnatti N, Legrand P, Journet L, Fronzes R, Mignot T, Cambillau C, Cascales E. 2016. Priming and polymerization of a bacterial contractile tail structure. Nature 531:59–63. 10.1038/nature17182. [DOI] [PubMed] [Google Scholar]
  • 55.Santin YG, Doan T, Lebrun R, Espinosa L, Journet L, Cascales E. 2018. In vivo TssA proximity labelling during type VI secretion biogenesis reveals TagA as a protein that stops and holds the sheath. Nat Microbiol 3:1304–1313. 10.1038/s41564-018-0234-3. [DOI] [PubMed] [Google Scholar]
  • 56.Ma L-S, Narberhaus F, Lai E-M. 2012. IcmF family protein TssM exhibits ATPase activity and energizes type VI secretion. J Biol Chem 287:15610–15621. 10.1074/jbc.M111.301630. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Bateman A, Coin L, Durbin R, Finn RD, Hollich V, Griffiths-Jones S, Khanna A, Marshall M, Moxon S, Sonnhammer ELL, Studholme DJ, Yeats C, Eddy SR. 2004. The Pfam protein families database. Nucleic Acids Res 32:D138–D141. 10.1093/nar/gkh121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Yokoyama K, Ishijima SA, Clowney L, Koike H, Aramaki H, Tanaka C, Makino K, Suzuki M. 2006. Feast/famine regulatory proteins (FFRPs): Escherichia coli Lrp, AsnC and related archaeal transcription factors. FEMS Microbiol Rev 30:89–108. 10.1111/j.1574-6976.2005.00005.x. [DOI] [PubMed] [Google Scholar]
  • 59.Yu Y, Yang H, Li J, Zhang P, Wu B, Zhu B, Zhang Y, Fang W. 2012. Putative type VI secretion systems of Vibrio parahaemolyticus contribute to adhesion to cultured cell monolayers. Arch Microbiol 194:827–835. 10.1007/s00203-012-0816-z. [DOI] [PubMed] [Google Scholar]
  • 60.Salomon D, Gonzalez H, Updegraff BL, Orth K. 2013. Vibrio parahaemolyticus type VI secretion system 1 is activated in marine conditions to target bacteria, and is differentially regulated from system 2. PLoS One 8:e61086. 10.1371/journal.pone.0061086. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Cherrak Y, Rapisarda C, Pellarin R, Bouvier G, Bardiaux B, Allain F, Malosse C, Rey M, Chamot-Rooke J, Cascales E, Fronzes R, Durand E. 2018. Biogenesis and structure of a type VI secretion baseplate. Nat Microbiol 3:1404–1416. 10.1038/s41564-018-0260-1. [DOI] [PubMed] [Google Scholar]
  • 62.Brunet YR, Zoued A, Boyer F, Douzi B, Cascales E. 2015. The type VI secretion TssEFGK-VgrG phage-like baseplate is recruited to the TssJLM membrane complex via multiple contacts and serves as assembly platform for tail tube/sheath polymerization. PLoS Genet 11:e1005545. 10.1371/journal.pgen.1005545. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Decoin V, Barbey C, Bergeau D, Latour X, Feuilloley MG, Orange N, Merieau A. 2014. A type VI secretion system is involved in Pseudomonas fluorescens bacterial competition. PLoS One 9:e89411. 10.1371/journal.pone.0089411. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Reese MG. 2001. Application of a time-delay neural network to promoter annotation in the Drosophila melanogaster genome. Comput Chem 26:51–56. 10.1016/s0097-8485(01)00099-7. [DOI] [PubMed] [Google Scholar]
  • 65.Reese MG. 2000. Computational prediction of gene structure and regulation in the genome of Drosophila melanogaster. PhD thesis. University of California, Berkeley, CA. [Google Scholar]
  • 66.Verstraeten N, Fauvart M, Versées W, Michiels J. 2011. The universally conserved prokaryotic GTPases. Microbiol Mol Biol Rev 75:507–542. 10.1128/MMBR.00009-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Hwang J, Inouye M. 2008. RelA functionally suppresses the growth defect caused by a mutation in the G domain of the essential Der protein. J Bacteriol 190:3236–3243. 10.1128/JB.01758-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Perault AI, Cotter PA. 2018. Three distinct contact-dependent growth inhibition systems mediate interbacterial competition by the cystic fibrosis pathogen Burkholderia dolosa. J Bacteriology 200:e00428-18. 10.1128/JB.00428-18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Dunn AK, Martin MO, Stabb EV. 2005. Characterization of pES213, a small mobilizable plasmid from Vibrio fischeri. Plasmid 54:114–134. 10.1016/j.plasmid.2005.01.003. [DOI] [PubMed] [Google Scholar]
  • 70.Stabb EV, Ruby EG. 2002. RP4-based plasmids for conjugation between Escherichia coli and members of the Vibrionaceae. Methods Enzymol 358:413–426. 10.1016/s0076-6879(02)58106-4. [DOI] [PubMed] [Google Scholar]
  • 71.Herrero M, de Lorenzo V, Timmis KN. 1990. Transposon vectors containing non-antibiotic resistance selection markers for cloning and stable chromosomal insertion of foreign genes in Gram-negative bacteria. J Bacteriol 172:6557–6567. 10.1128/jb.172.11.6557-6567.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Hanahan D. 1983. Studies on transformation of Escherichia coli with plasmids. J Mol Biol 166:557–580. 10.1016/s0022-2836(83)80284-8. [DOI] [PubMed] [Google Scholar]
  • 73.Saavedra JT, Schwartzman JA, Gilmore MS. 2017. Mapping transposon insertions in bacterial genomes by arbitrarily primed PCR. Curr Protoc Mol Biol 118:15.15.1–15.15.15. 10.1002/cpmb.38. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Adin DM, Visick KL, Stabb EV. 2008. Identification of a cellobiose utilization gene cluster with cryptic β-galactosidase activity in Vibrio fischeri. Appl Environ Microbiol 74:4059–4069. 10.1128/AEM.00190-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Li MZ, Elledge SJ. 2012. SLIC: a method for sequence- and ligation-independent cloning. Methods Mol Biol 852:51–59. 10.1007/978-1-61779-564-0_5. [DOI] [PubMed] [Google Scholar]
  • 76.Wiśniewski JR, Mann M. 2009. Reply to “Spin filter–based sample preparation for shotgun proteomics. Nat Methods 6:785–786. 10.1038/nmeth1109-785b. [DOI] [PubMed] [Google Scholar]
  • 77.Kleiner M, Thorson E, Sharp CE, Dong X, Liu D, Li C, Strous M. 2017. Assessing species biomass contributions in microbial communities via metaproteomics. Nat Commun 8:1–14. 10.1038/s41467-017-01544-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Zybailov B, Mosley AL, Sardiu ME, Coleman MK, Florens L, Washburn MP. 2006. Statistical analysis of membrane proteome expression changes in Saccharomyces cerevisiae. J Proteome Res 5:2339–2347. 10.1021/pr060161n. [DOI] [PubMed] [Google Scholar]
  • 79.Vizcaíno JA, Csordas A, del-Toro N, Dianes JA, Griss J, Lavidas I, Mayer G, Perez-Riverol Y, Reisinger F, Ternent T, Xu Q-W, Wang R, Hermjakob H. 2016. 2016 update of the PRIDE database and its related tools. Nucleic Acids Res 44:D447–D456. 10.1093/nar/gkv1145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Xu D, Zhang Y. 2012. Ab initio protein structure assembly using continuous structure fragments and optimized knowledge-based force field. Proteins 80:1715–1735. 10.1002/prot.24065. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Xu D, Zhang Y. 2013. Toward optimal fragment generations for ab initio protein structure assembly. Proteins 81:229–239. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplemental file 1

Table S1. Download JB.00399-21-s0001.xlsx, XLSX file, 0.3 MB (299KB, xlsx)

Supplemental file 2

Table S2. Download JB.00399-21-s0002.xlsx, XLSX file, 0.09 MB (95.5KB, xlsx)

Supplemental file 3

Table S3. Download JB.00399-21-s0003.xlsx, XLSX file, 0.09 MB (96.6KB, xlsx)

Supplemental file 4

Table S4. Download JB.00399-21-s0004.xlsx, XLSX file, 0.09 MB (95.5KB, xlsx)

Supplemental file 5

Fig. S1 to S5 and Table S5. Download JB.00399-21-s0005.pdf, PDF file, 0.3 MB (434.4KB, pdf)

Data Availability Statement

The mass spectrometry proteomics data and protein sequence database have been deposited in the ProteomeXchange Consortium via the PRIDE (79) partner repository under the data set identifier PXD017722.


Articles from Journal of Bacteriology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES